Molecular analysis of primary melanoma T cells identifies patients at risk for metastatic recurrence.

MLA

Pruessmann, Wiebke, et al. “Molecular Analysis of Primary Melanoma T Cells Identifies Patients at Risk for Metastatic Recurrence.” Nature Cancer, vol. 1, no. 2, Feb. 2020, pp. 197–209. EBSCOhost, https://doi.org/10.1038/s43018-019-0019-5.

APA

Pruessmann, W., Rytlewski, J., Wilmott, J., Mihm, M. C., Jr, Attrill, G. H., Dyring-Andersen, B., Fields, P., Zhan, Q., Colebatch, A. J., Ferguson, P. M., Thompson, J. F., Kallenbach, K., Yusko, E., Clark, R. A., Robins, H., Scolyer, R. A., & Kupper, T. S. (2020). Molecular analysis of primary melanoma T cells identifies patients at risk for metastatic recurrence. Nature Cancer, 1(2), 197–209. https://doi.org/10.1038/s43018-019-0019-5

Chicago

Pruessmann, Wiebke, Julie Rytlewski, James Wilmott, Martin C Mihm Jr, Grace H Attrill, Beatrice Dyring-Andersen, Paul Fields, et al. 2020. “Molecular Analysis of Primary Melanoma T Cells Identifies Patients at Risk for Metastatic Recurrence.” Nature Cancer 1 (2): 197–209. doi:10.1038/s43018-019-0019-5.